Rural Health
Resources by Topic: Prescription drug misuse
Factors Associated with Gaps in Naloxone Knowledge: Evidence from a 2022 Great Plains Survey
Examines naloxone knowledge in Nebraska, such as familiarity with, access to, and competency administering naloxone. Analyzes 2022 Nebraska Annual Social Indicators Survey data with breakdowns according to respondent substance use, social and demographic data, and metro versus nonmetro location. Discusses issues such as naloxone access, education, and stigma related to opioid-related overdose deaths.
Author(s): Spencer Cooper-Ohm, Patrick Habecker, Ryan Humeniuk, Rick A. Bevins
Citation: Harm Reduction Journal, 21, 37
Date: 02/2024
view details
Examines naloxone knowledge in Nebraska, such as familiarity with, access to, and competency administering naloxone. Analyzes 2022 Nebraska Annual Social Indicators Survey data with breakdowns according to respondent substance use, social and demographic data, and metro versus nonmetro location. Discusses issues such as naloxone access, education, and stigma related to opioid-related overdose deaths.
Author(s): Spencer Cooper-Ohm, Patrick Habecker, Ryan Humeniuk, Rick A. Bevins
Citation: Harm Reduction Journal, 21, 37
Date: 02/2024
view details
Stakeholder Perspectives on a Telemedicine Referral and Coordination Model To Expand Medication Treatment for Opioid Use Disorder in Rural Primary Care Clinics
Examines acceptability of utilizing an external telemedicine (TM) vendor to improve access to medications for opioid use disorder (MOUD) in rural areas. Analyzes interview data from 7 rural primary care clinics and a TM-MOUD vendor to explore themes such as logistical barriers, stigma, privacy, and access. Includes demographic data on survey respondents as well as acceptability ratings.
Author(s): Allison J. Ober, Alex R. Dopp, Sarah E. Clingan, et al.
Citation: Journal of Substance Use and Addiction Treatment, 156, 209194
Date: 01/2024
view details
Examines acceptability of utilizing an external telemedicine (TM) vendor to improve access to medications for opioid use disorder (MOUD) in rural areas. Analyzes interview data from 7 rural primary care clinics and a TM-MOUD vendor to explore themes such as logistical barriers, stigma, privacy, and access. Includes demographic data on survey respondents as well as acceptability ratings.
Author(s): Allison J. Ober, Alex R. Dopp, Sarah E. Clingan, et al.
Citation: Journal of Substance Use and Addiction Treatment, 156, 209194
Date: 01/2024
view details
Medicaid Coverage of Medications to Reverse Opioid Overdose and Treat Alcohol and Opioid Use Disorders
Report discusses access to medications for treating alcohol use disorder (AUD) and opioid use disorder (OUD) via Medicaid. Highlights policies and regulations that effect access and details Medicaid coverage in all 50 states, the District of Columbia, the U.S Virgin Islands, and Puerto Rico. Features a discussion about rural access.
Date: 01/2024
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Report discusses access to medications for treating alcohol use disorder (AUD) and opioid use disorder (OUD) via Medicaid. Highlights policies and regulations that effect access and details Medicaid coverage in all 50 states, the District of Columbia, the U.S Virgin Islands, and Puerto Rico. Features a discussion about rural access.
Date: 01/2024
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
A Federally Qualified Health Center and Certified Community Behavioral Health Clinic Partnership in Rural Missouri
Case study describing a medication for opioid use disorder (MOUD) program partnership between a Federally Qualified Health Center and a certified community behavioral health clinic in rural southwest Missouri. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers interested in a similar partnership.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
Case study describing a medication for opioid use disorder (MOUD) program partnership between a Federally Qualified Health Center and a certified community behavioral health clinic in rural southwest Missouri. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers interested in a similar partnership.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
El Dorado Community Health Centers: Addressing the Opioid Epidemic in Rural California through Community Partnerships
Case study describing how El Dorado Community Health Centers, a Federally Qualified Health Center (FQHC) in California, works with a community coalition to address the opioid epidemic and implement a medication for opioid use disorder (MOUD) program. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
Case study describing how El Dorado Community Health Centers, a Federally Qualified Health Center (FQHC) in California, works with a community coalition to address the opioid epidemic and implement a medication for opioid use disorder (MOUD) program. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
Opioid Overdose Surveillance Preliminary District Report: Georgia, 2022
Describes district-level fatal and nonfatal opioid-involved overdoses that occurred in Georgia 2020-2022. Covers prescription opioids and illicit opioids, including heroin, fentanyl, and fentanyl analogs. Features statistics on demographics, overdose deaths, and emergency department visits, with breakdowns by district, drug type, and year. The Preliminary County Report contains county-by-county data.
Additional links: County Report
Date: 01/2024
Sponsoring organization: Georgia Department of Public Health
view details
Describes district-level fatal and nonfatal opioid-involved overdoses that occurred in Georgia 2020-2022. Covers prescription opioids and illicit opioids, including heroin, fentanyl, and fentanyl analogs. Features statistics on demographics, overdose deaths, and emergency department visits, with breakdowns by district, drug type, and year. The Preliminary County Report contains county-by-county data.
Additional links: County Report
Date: 01/2024
Sponsoring organization: Georgia Department of Public Health
view details
Risk Factors for Adolescent Drug and Alcohol Abuse in Arkansas 2024
Provides state, region, and county-level data for Arkansas related to substance abuse by youth. Identifies risk factors associated with drug and alcohol abuse, such as the number of arrests, unemployment, school infractions, tobacco and cannabis retailers, and more, as well as associated public health outcomes such as substance use-related mortality.
Date: 2024
Sponsoring organizations: Arkansas Department of Human Services, Arkansas Foundation for Medical Care, UA Little Rock MidSOUTH Center for Prevention and Training
view details
Provides state, region, and county-level data for Arkansas related to substance abuse by youth. Identifies risk factors associated with drug and alcohol abuse, such as the number of arrests, unemployment, school infractions, tobacco and cannabis retailers, and more, as well as associated public health outcomes such as substance use-related mortality.
Date: 2024
Sponsoring organizations: Arkansas Department of Human Services, Arkansas Foundation for Medical Care, UA Little Rock MidSOUTH Center for Prevention and Training
view details
"I Don't Think That a Medication Is Going to Help Someone Long-Term Stay off Opioids": Treatment and Recovery Beliefs of Rural Vermont Family Members of People with Opioid Use Disorder
Examines beliefs related to opioid use disorder (OUD) treatment and recovery from the perspective of the family members of people with OUD. Analyzes interview data from 20 rural Vermont family members and discusses themes such as medication for OUD (MOUD), OUD treatment and mental health services, patient readiness for OUD treatment, and stigma.
Author(s): Catherine E. Peasley-Miklus, Julia G. Shaw, Katie Rosingana, et al.
Citation: Journal of Rural Health, 40(4), 681-688
Date: 2024
view details
Examines beliefs related to opioid use disorder (OUD) treatment and recovery from the perspective of the family members of people with OUD. Analyzes interview data from 20 rural Vermont family members and discusses themes such as medication for OUD (MOUD), OUD treatment and mental health services, patient readiness for OUD treatment, and stigma.
Author(s): Catherine E. Peasley-Miklus, Julia G. Shaw, Katie Rosingana, et al.
Citation: Journal of Rural Health, 40(4), 681-688
Date: 2024
view details
Primary Care Professionals' Perspectives on Tailoring Buprenorphine Training for Rural Practice
Interviewed 23 rural Ohio primary care professionals to identify barriers to prescribing buprenorphine for opioid use disorder treatment. Discusses the need for training addressing rural-specific barriers, limited patient access to required social supports, workforce, and stigma. Offers recommendations based on findings.
Author(s): Cheyenne Fenstemaker, Elizabeth A. Abrams, Benjamin Obringer, et al.
Citation: Journal of Rural Health, 40(4), 671-680
Date: 2024
view details
Interviewed 23 rural Ohio primary care professionals to identify barriers to prescribing buprenorphine for opioid use disorder treatment. Discusses the need for training addressing rural-specific barriers, limited patient access to required social supports, workforce, and stigma. Offers recommendations based on findings.
Author(s): Cheyenne Fenstemaker, Elizabeth A. Abrams, Benjamin Obringer, et al.
Citation: Journal of Rural Health, 40(4), 671-680
Date: 2024
view details
Defining and Evaluating In-Home Drug Disposal Systems for Opioid Analgesics: Proceedings of a Workshop
Offers summary of a June 2023 workshop to analyze in-home drug disposal systems with focus on unused opioid analgesics. Discusses the life cycle of prescribed opioids, characteristics of in-home disposal systems, implementation and equity concerns, legal concerns, environmental impacts, and real-world settings. Includes discussions of tribal and rural-specific challenges and benefits.
Additional links: Read Online
Author(s): Board on Health Sciences Policy
Date: 2024
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
Offers summary of a June 2023 workshop to analyze in-home drug disposal systems with focus on unused opioid analgesics. Discusses the life cycle of prescribed opioids, characteristics of in-home disposal systems, implementation and equity concerns, legal concerns, environmental impacts, and real-world settings. Includes discussions of tribal and rural-specific challenges and benefits.
Additional links: Read Online
Author(s): Board on Health Sciences Policy
Date: 2024
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details